phenylephrine + sodium nitroprusside

Phenylephrine + sodium nitroprusside is a combination of two vasoactive agents with opposing mechanisms of action, used primarily in research and specialized clinical settings to manipulate vascular tone and blood pressure. Phenylephrine is an alpha-1 adrenergic receptor agonist that induces vasoconstriction, increasing systemic vascular resistance and arterial pressure. Sodium nitroprusside is a direct-acting vasodilator that releases nitric oxide, leading to increased cGMP in vascular smooth muscle cells and resulting in both arterial and venous dilation. This combination allows for precise control of blood flow dynamics during procedures or experimental protocols where rapid modulation between vasoconstriction (phenylephrine) and vasodilation (sodium nitroprusside) is required[1][2][3][5][6].

Other names

nitroprusside + phenylephrine-Mayo Clinicsodium nitroprusside and phenylephrine hydrochloride